TRPM4 enhances cell proliferation through up-regulation of the β-catenin signaling pathway

Journal of Cellular Physiology

Volumn 226, Issue 1, 2011, Pages 103-109

  Armisén, Ricardo ^a   Marcelain, Katherine ^a   Simon, Felipe ^a   Tapia, Julio C ^a   Toro, Jessica ^a   Quest, Andrew F G ^a   Stutzin, Andrés ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4;

ARTICLE; CANCER CELL; CELL PROLIFERATION; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; UTERINE CERVIX CANCER;

BETA CATENIN; CELL LINE; CELL PROLIFERATION; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TRPM CATION CHANNELS; UP-REGULATION;

EID: 78049294716     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22310     Document Type: Article

References (44)

1. Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y, Tsunoda T, Takata R, Kasahara K, Miki T, Fujioka T, Shuin T, Nakamura Y. 2004. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 64: 5963-5972.
2. Barbet G, Demion M, Moura IC, Serafini N, Leger T, Vrtovsnik F, Monteiro RC, Guinamard R, Kinet JP, Launay P. 2008. The calcium-activated nonselective cation channel TRPM4 is essential for the migration but not the maturation of dendritic cells. Nat Immunol 9: 1148-1156.
3. Behrens J. 2000. Control of β-catenin signaling in tumor development. Ann NY Acad Sci 910: 21-33.
4. Bienz M, Clevers H. 2000. Linking colorectal cancer to Wnt signaling. Cell 103: 311-320.
5. Birchmeier W, Behrens J. 1994. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198: 11-26.
6. Bödding M. 2007. TRP proteins and cancer. Cell Signal 19: 617-624.
7. Brantjes H, Barker N, van EJ, Clevers H. 2002. TCF: Lady justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 383: 255-261.
8. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC. 2000. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7: 793-803.
9. Coticchia C, Revankar C, Deb T, Dickson R, Johnson M. 2009. Calmodulin modulates Akt activity in human breast cancer cell lines. Breast Cancer Res Treat 115: 545-560.
10. Deb TB, Coticchia CM, Dickson RB. 2004. Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells. J Biol Chem 279: 38903-38911.
11. Dykxhoorn DM, Novina CD, Sharp PA. 2003. Killing the messenger: Short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4: 457-467.
12. Fonfria E, Murdock PR, Cusdin FS, Benham CD, Kelsell RE, McNulty S. 2006. Tissue distribution profiles of the human TRPM cation channel family. J Recept Signal Transduct Res 26: 159-178.
13. Fraser SP, Pardo LA. 2008. Ion channels: Functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Rep 9: 512-515.
14. Goni-Oliver P, Lucas JJ, Avila J, Hernandez F. 2007. N-terminal cleavage of GSK-3 by Calpain: A new form of GSK-3 regulation. J Biol Chem 282: 22406-22413.
15. Goode N, Hughes K, Woodgett JR, Parker PJ. 1992. Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes. J Biol Chem 267: 16878-16882.
16. Imura J, Ichikawa K, Takeda J, Fujimori T. 2001. β-Catenin expression as a prognostic indicator in cervical adenocarcinoma. Int J Mol Med 8: 353-358.
17. Jeanes A, Gottardi CJ, Yap AS. 2008. Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929.
18. Kim Y, Lee YI, Seo M, Kim SY, Lee JE, Youn HD, Kim YS, Juhnn YS. 2009. Calcineurin dephosphorylates glycogen synthase kinase-3β at serine-9 in neuroblast-derived cells. J Neurochem 111: 344-354.
19. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H. 1997. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
20. Kruse M, Schulze-Bahr E, Corfield V, Beckmann A, Stallmeyer B, Kurtbay G, Ohmert I, Schulze-Bahr E, Brink P, Pongs O. 2009. Impaired endocytosis of the ion channel TRPM4 is associated with human progressive familial heart block type I. J Clin Invest 119: 2737-2744.
21. 2+-activated nonselective cation channel mediating cell membrane depolarization. Cell 109: 397-407.
22. Launay P, Cheng H, Srivatsan S, Penner R, Fleig A, Kinet JP. 2004. TRPM4 regulates calcium oscillations after T cell activation. Science 306: 1374-1377.
23. Lee YI, Seo M, Kim Y, Kim SY, Kang UG, Kim YS, Juhnn YS. 2005. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3β, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells. J Biol Chem 280: 22044-22052.
24. Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL, Moreno CS. 2006. Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 66: 4011-4019.
25. Logan CY, Nusse R. 2004. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
26. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. 2004. WNT and β-catenin signalling: Diseases and therapies. Nat Rev Genet 5: 691-701.
27. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW. 1997. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790.
28. Narayan G, Bourdon V, Chaganti S, Arias-Pulido H, Nandula SV, Rao PH, Gissmann L, Durst M, Schneider A, Pothuri B, Mansukhani M, Basso K, Chaganti RS, Murty VV. 2007. Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer 46: 373-384.
29. 2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem 280: 6423-6433.
30. Prevarskaya N, Flourakis M, Bidaux G, Thebault S, Skryma R. 2007. Differential role of TRP channels in prostate cancer. Biochem Soc Trans 35: 133-135.
31. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H, Nardone J, Lee K, Reeves C, Li Y, Hu Y, Tan Z, Stokes M, Sullivan L, Mitchell J, Wetzel R, Macneill J, Ren JM, Yuan J, Bakalarski CE, Villen J, Kornhauser JM, Smith B, Li D, Zhou X, Gygi SP, Gu TL, Polakiewicz RD, Rush J, Comb MJ. 2007. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203.
32. Rodriguez DA, Tapia JC, Fernandez JG, Torres VA, Munoz N, Galleguillos D, Leyton L, Quest AF. 2009. Caveolin-1-mediated suppression of cyclooxygenase-2 via a β-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression. Mol Biol Cell 20: 2297-2310.
33. Shimizu T, Owsianik G, Freichel M, Flockerzi V, Nilius B, Vennekens R. 2009. TRPM4 regulates migration of mast cells in mice. Cell Calcium 45: 226-232.
34. Singh J, Manickam P, Shmoish M, Natik S, Denyer G, Handelsman D, Gong DW, Dong Q. 2006. Annotation of androgen dependence to human prostate cancer-associated genes by microarray analysis of mouse prostate. Cancer Lett 237: 298-304.
35. Suguro M, Tagawa H, Kagami Y, Okamoto M, Ohshima K, Shiku H, Morishima Y, Nakamura S, Seto M. 2006. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: Development of a CD5 signature. Cancer Sci 97: 868-874.
36. Tapia JC, Torres VA, Rodriguez DA, Leyton L, Quest AF. 2006. Casein kinase 2 (CK2) increases survivin expression via enhanced β-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription. Proc Natl Acad Sci USA 103: 15079-15084.
37. Torres VA, Tapia JC, Rodríguez DA, Párraga M, Lisboa P, Montoya M, Leyton L, Quest AF. 2006. Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci 119: 1812-1823.
38. Torres VA, Tapia JC, Rodríguez DA, Lladser A, Arredondo C, Leyton L, Quest AF. 2007. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced β-catenin-Tcf/Lef-dependent transcription. Mol Cell Biol 27: 7703-7717.
39. van de Wetering M, Cavallo R, Dooijes D, van BM, van EJ, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H. 1997. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88: 789-799.
40. Venkatachalam K, Montell C. 2007. TRP channels. Annu Rev Biochem 76: 387-417.
41. Vennekens R, Nilius B. 2007. Insights into TRPM4 function, regulation and physiological role. Handb Exp Pharmacol 179: 269-285.
42. Vennekens R, Olausson J, Meissner M, Bloch W, Mathar I, Philipp SE, Schmitz F, Weissgerber P, Nilius B, Flockerzi V, Freichel M. 2007. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat Immunol 8: 312-320.
43. Wong NA, Pignatelli M. 2002. β-catenin-A linchpin in colorectal carcinogenesis? Am J Pathol 160: 389-401.
44. Zanivan S, Gnad F, Wickström SA, Geiger T, Macek B, Cox J, Fässler R, Mann M. 2008. Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry. J Proteome Res 7: 5314-5326.